Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data.
Guillermo Ruiz-IrastorzaJose-Ignacio PijoanElena BereciartuaSusanna DunderJokin DominguezPaula Garcia-EscuderoAlejandro RodrigoCarlota Gomez-CarballoJimena VaronaLaura GuioMarta IbarrolaAmaia UgarteAgustin Martinez-Berriotxoanull nullPublished in: PloS one (2020)
Week-2-MP are effective in improving the prognosis of patients with COVID-19 pneumonia with features of inflammatory activity and respiratory deterioration entering the second week of disease. The recognition of this high-risk population should prompt early use of MP at this point.
Keyphrases
- coronavirus disease
- healthcare
- placebo controlled
- palliative care
- electronic health record
- early onset
- clinical practice
- quality improvement
- respiratory failure
- big data
- community acquired pneumonia
- clinical trial
- pain management
- intensive care unit
- machine learning
- affordable care act
- deep learning
- double blind
- health insurance